Medical technology sector

Life sciences investment giant to give Singapore medtech start-ups international boost

Dr Tan See Leng, Minister-in-charge of Energy and Science & Technology in MTI delivering a speech during the Singapore Medical Device Showcase on June 29, 2026.

From student project to start-up: RP grads develop AI-powered camera system for stroke detection

Republic Poly students (from left) Sasindren Jaya Sanger, Sarah Beegam Saju, Ashwin Manikandan, and Tan Jia Ling Jolin, with their AI-powered stroke detection system.

Why hospitals in China, including Raffles Medical, are attracting more foreign patients

SinoUnited Health is one of the hospitals in China that has been treating international patients.

‘It’s still working’: More are living with cancer as era of targeted drugs takes hold

Menta “Steve” Wallace and his wife, Jo Linda, at their home in Texas. Menta is taking the experimental pancreatic cancer drug daraxonrasib.

J&J drug Erleada reduces risk of prostate cancer spread, death

Prostrate cancer patients who were on Erleada and hormone-blocking therapy went more than six years before requiring subsequent treatment.

Lung cancer patients on drug from China’s Akeso lived longer

The new study by Chinese firm Akeso targeted squamous non-small cell lung cancer, a condition often linked with smoking.

Experimental pancreatic cancer pill doubles survival chances, boosts quality of life

Revolution Medicine’s daraxonrasib drug reduced the time from diagnosis of pancreatic cancer to a patient’s death to 13.2 months versus 6.7 months for those on standard chemotherapy.

Doctors, this is why our patients are using ChatGPT

ChatGPT behaved the way this doctor wished modern medicine and its practitioners would.

From lab idea to $2.9b start-up: Ultrasound destroys cancer without scalpels

HistoSonics, founded by China-born scientist Zhen Xu, pioneers a technique that uses ultrasound technology to target cancer cells.

AI spots pancreatic cancer years before it shows up: US study

More than 85 per cent of pancreatic cancer cases are found at a stage where treatment is largely limited to easing symptoms, with the five-year survival rate at about 10 per cent globally.

E-paper

Newsletters

Podcasts

RSS Feed

About Us

Terms & Conditions

Personal Data Protection Notice

Need help? Reach us here.

Advertise with us

MDDI (P) 046/10/2025. Published by SPH Media Limited, Co. Regn. No.202120748H. Copyright © 2026 SPH Media Limited. All rights reserved.